Ziopharm CEO Jonathan Lewis Calls For Faster Cancer Drug Development; Drug Candidates Linger Too Long In Irrelevant Animal Studies; Decision To Ditch A Molecule Needs To Come Much Quicker

New cancer treatments could be developed faster and cheaper if outdated study strategies were replaced with more relevant science-based methods designed to facilitate faster decisions.

MORE ON THIS TOPIC